Randomized Trial of a Depression Management Program in High Utilizers of Medical Care
Overview
Authors
Affiliations
Background: High utilizers of nonpsychiatric health care services have disproportionally high rates of undiagnosed or undertreated depression.
Objective: To determine the impact of offering a systematic primary care-based depression treatment program to depressed "high utilizers" not in active treatment.
Design: Randomized clinical trial.
Setting: One hundred sixty-three primary care practices in 3 health maintenance organizations located in different geographic regions of the United States.
Patients: A group of 1465 health maintenance organization members were identified as depressed high utilizers using a 2-stage telephone screening process. Eligibility criteria were met by 410 patients and 407 agreed to enroll: 218 in the depression management program (DMP) practices and 189 in the usual care (UC) group.
Intervention: The DMP included patient education materials, physician education programs, telephone-based treatment coordination, and antidepressant pharmacotherapy initiated and managed by patients' primary care physicians.
Main Outcome Measures: Depression severity was measured using the Hamilton Depression Rating Scale (Ham-D) and functional status using the Medical Outcomes Study 20-item short form (SF-20) subscales. Outpatient visit and hospitalization rates were measured using the health plan's encounter data.
Results: Based on an intent-to-treat analysis, at least 3 antidepressant prescriptions were filled in the first 6 months by 151 (69.3%) of 218 of DMP patients vs 35 (18.5%) of 189 in UC (P < .001). Improvements in Ham-D scores were significantly greater in the intervention group at 6 weeks (P = .04), 3 months (P = .02), 6 months (P < .001), and 12 months (P < .001). At 12 months, DMP intervention patients were more improved than UC patients on the mental health, social functioning, and general health perceptions scales of the SF-20 (P < .05 for all).
Conclusion: In depressed high utilizers not already in active treatment, a systematic primary care-based treatment program can substantially increase adequate antidepressant treatment, decrease depression severity, and improve general health status compared with usual care.
Gonzalez-Ruiz J, Granero-Gallegos A, Marin-Marin J, Moreno-Guerrero A Pediatr Rep. 2024; 16(4):1169-1187.
PMID: 39728740 PMC: 11676241. DOI: 10.3390/pediatric16040099.
Bonsel J, Itiola A, Huberts A, Bonsel G, Penton H Health Qual Life Outcomes. 2024; 22(1):101.
PMID: 39593045 PMC: 11600902. DOI: 10.1186/s12955-024-02312-4.
Promoting Psychodermatology; too few Psychocutaneous articles in leading dermatology journals.
Mostaghimi L J Eur Acad Dermatol Venereol. 2022; 37(3):e380-e381.
PMID: 36149302 PMC: 9928600. DOI: 10.1111/jdv.18579.
'Psychodermatology': The present standing and a path forward.
Mostaghimi L, Noughani H J Eur Acad Dermatol Venereol. 2022; 36(8):1162-1163.
PMID: 35848144 PMC: 9543115. DOI: 10.1111/jdv.18278.
Chang E, Ali R, Berkman N BMJ Open. 2022; 12(6):e058539.
PMID: 35680272 PMC: 9185578. DOI: 10.1136/bmjopen-2021-058539.